HillMed was proud to participate in the 120th American Urological Association (AUA) Annual Meeting, held April 26-29, 2025 in Las Vegas. As the premier global event for urology professionals, AUA 2025 brought together thousands of clinicians, researchers and innovators to explore the latest advancements in urologic care.
Throughout the conference, HillMed engaged with a diverse range of stakeholders, including leading clinicians, key opinion leaders and potential partners. These interactions provided valuable feedback on our technology and fostered discussions on collaborative opportunities to advance EMG applications in urology and beyond.
The AUA 2025 program featured numerous sessions highlighting the role of advanced diagnostics in urologic care.The emphasis on precision medicine and personalized treatment strategies underscored the relevance of HillMed’s mission to deliver clarity and confidence through innovative EMG solutions and create more beneficial means to spasticity management.
Looking ahead, HillMed remains committed to advancing our EMG system through continued product development, regulatory engagement and manufacturing efforts. Our experience at AUA 2025 reinforced our dedication to transforming neuromuscular diagnosis and treatment, ultimately improving patient outcomes.
